286 related articles for article (PubMed ID: 4393830)
1. [Effect of alkyl derivatives of cysteamine and cystamine and some aminoalkyldisulfides on central nervous system].
Smaĭlene AA; Slavachevskaia NM
Farmakol Toksikol; 1970; 33(3):271-5. PubMed ID: 4393830
[No Abstract] [Full Text] [Related]
2. [Experimental study of the pharmacological effect of oxyphenamate].
Gorshkova VK; Mikhaĭlova TV; Gilev AP
Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696
[No Abstract] [Full Text] [Related]
3. [Changes in the functional condition of the central nervous system under the action of cystamine and some of its derivatives].
Generalov VI
Farmakol Toksikol; 1966; 29(5):548-50. PubMed ID: 5995065
[No Abstract] [Full Text] [Related]
4. [Effect of formamide and of its N-methylated and N-ethylated derivatives on the effects of convulsants and hypnotics].
Pham-Huu-Chanh ; Azum-Gelade MC; Nguyen-Van-Bac ; Nguyen-Dat-Xuong
Therapie; 1972; 27(5):873-80. PubMed ID: 4405588
[No Abstract] [Full Text] [Related]
5. [Pharmacology of derivatives with oxime function: 2-hydroxy-3-methoxy-benzaldoxime].
Pham-Huu-Chanh ; Chanvattey S; Azum-Gelade MC; Silve-Mamy G
Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):443-58. PubMed ID: 4391898
[No Abstract] [Full Text] [Related]
6. [Course of experimental convulsions under the action of some aminothiols].
Bodakva AP
Farmakol Toksikol; 1967; 30(4):482-3. PubMed ID: 5598908
[No Abstract] [Full Text] [Related]
7. Studies on some aspects of the neuropharmacology of butylurea.
Dar MS; Fakouhi T
Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473
[No Abstract] [Full Text] [Related]
8. [Effect of vincarin on the central nervous system].
Khanov M; Kurmukov AG; Sultanov MB; Akhmedkhodzhaeva KhS
Farmakol Toksikol; 1968; 31(5):538-41. PubMed ID: 4387717
[No Abstract] [Full Text] [Related]
9. The influence of substituted derivatives of phenyldiallylacetamide on the central nervous system.
Zak A; Prastowski W
Arch Immunol Ther Exp (Warsz); 1966; 14(5):657-61. PubMed ID: 5923830
[No Abstract] [Full Text] [Related]
10. [Effect of alaphen on some functions of central nervous system].
Masiuta GF
Farmakol Toksikol; 1966; 29(5):524-7. PubMed ID: 5995061
[No Abstract] [Full Text] [Related]
11. [Central effects of betamezide].
Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
[No Abstract] [Full Text] [Related]
12. Effect of p-chlorophenylalanine on the central nervous excitability threshold and on the activity of some central depressants.
Georgiev VP; Petkova BP
Med Biol; 1975 Feb; 53(1):47-50. PubMed ID: 124805
[TBL] [Abstract][Full Text] [Related]
13. [Demonstration of a depressive component in the central effects of nikethamide].
Buchel L; Absil J
Arch Sci Physiol (Paris); 1972; 26(2):175-94. PubMed ID: 4265482
[No Abstract] [Full Text] [Related]
14. [Neurotropic properties of aminooxyacetic acid and gamma-aminooxybutyric acid].
Ostrovskaia RU; Artemenko GN; Raevskii KS
Farmakol Toksikol; 1970; 33(2):137-42. PubMed ID: 4393231
[No Abstract] [Full Text] [Related]
15. [Effect of benzonal and benzamyl on some functional indices of central nervous system].
Dumenova EM
Farmakol Toksikol; 1966; 29(5):522-4. PubMed ID: 4384927
[No Abstract] [Full Text] [Related]
16. [On the relationship between chemical structure and central N-cholinolytic action in acetylene amines and their saturated analogues].
Zatsepln EP
Farmakol Toksikol; 1968; 31(4):431-4. PubMed ID: 5698133
[No Abstract] [Full Text] [Related]
17. [Effect of triterpene glycosides of Patrinia intermedia Roem. et Schult on the central nervous system].
Lapik AS; Bukharov VG; Talan VA; Karlin VV
Farmakol Toksikol; 1968; 31(6):650-2. PubMed ID: 5713574
[No Abstract] [Full Text] [Related]
18. [Effect of new pyrazolo-(1,2-a)-1,2,5-triazepine derivatives on the central nervous system].
Szadowska A; Mazur M; Kamińska A; Kusowska J; Winer A
Acta Pol Pharm; 1982; 39(5-6):463-67. PubMed ID: 7171016
[No Abstract] [Full Text] [Related]
19. [Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions].
Vikhliaev IuI; Klygul' TA; Prokudin VN; Adronati SA
Farmakol Toksikol; 1971; 34(1):30-5. PubMed ID: 5563373
[No Abstract] [Full Text] [Related]
20. Stereostructure-activity relationships for oxazepam hemisuccinate. Effects on central nervous system.
de Angelis L; Predominato M; Vertua R
Arzneimittelforschung; 1972 Aug; 22(8):1328-33. PubMed ID: 4678394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
